Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-28T20:02:48.393Z Has data issue: false hasContentIssue false
  • English
  • Français

Introduction

Published online by Cambridge University Press:  01 January 2021

Larry R. Churchill  and
Joshua E. Perry
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Introduction
Information
Journal of Law, Medicine & Ethics , Volume 42 , Issue 4 , Winter 2014 , pp. 408 - 411
Copyright
Copyright © American Society of Law, Medicine and Ethics 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

See Relman, A. S., “The Medical Industrial Complex,” New England Journal of Medicine 303, no. 17 (1980): 963–970,and his subsequent writings on this topic: “The Health Care Industry: Where is it Taking Us?” New England Journal of Medicine 325, no. 12 (1991): 854–859;“Medical Professionalism in a Commercialized Health Care Market,” JAMA 298, no. 22 (2007): 2668–2670.CrossRefGoogle Scholar
The concept “Medical-industrial complex” was introduced in 1970 by B. Ehrenreich and J. Ehrenreich in The American Health Empire: Power Politics and Profits (New York: Random House, 1970).Google Scholar
Marmor, T. R. Gordon, R. W., “Commercial Pressures on Professionalism in American Medical Care: From Medicare to the Affordable Care Act,” Journal of Law, Medicine & Ethics 42, no. 4 (2014): 412–419.CrossRefGoogle Scholar
Wicks, A. C. Keevil, A. A. C., “When Worlds Collide: Medicine, Business, the Affordable Care Act and the Future of Health Care in the U.S.,” Journal of Law, Medicine & Ethics 42, no. 4 (2014): 412–419.CrossRefGoogle Scholar
Oberlander, J., “Between Liberal Aspirations and Market Forces: Obamacare's Precarious Balancing Act,” Journal of Law, Medicine & Ethics 42, no. 4 (2014): 420–441.CrossRefGoogle Scholar
Halabi, S., “Selling Hospice,” Journal of Law, Medicine & Ethics 42, no. 4 (2014): 442–454.CrossRefGoogle Scholar
Perry, J. E. Stone, R. C., “In the Business of Dying: Questioning the Commercialization of Hospice,” Journal of Law, Medicine & Ethics 39, no. 2 (2011): 224–234.CrossRefGoogle Scholar
Fletcher, J. Marriott, J., “Beyond the Market: The Role of Constitutions in Health Care System Convergence in the United States of America and the United Kingdom,” Journal of Law, Medicine & Ethics 42, no. 4 (2014): 455–474.CrossRefGoogle Scholar
Perry, J. E. Cox, D. Cox, A. D., “Trust and Transparency: Patient Perceptions of Physicians' Financial Relationships with Pharmaceutical Companies,” Journal of Law, Medicine & Ethics 42, no. 4 (2014): 475–491.CrossRefGoogle Scholar
Lamkin, M. Elliott, C., “Curing the Disobedient Patient: Medication Adherence Programs as Pharmaceutical Marketing Tools,” Journal of Law, Medicine & Ethics 42, no. 4 (2014): 492–500.CrossRefGoogle Scholar
Brody, H., “Economism and the Commercialization of Health Care,” Journal of Law, Medicine & Ethics 42, no. 4 (2014): 501–508.CrossRefGoogle Scholar
Shepherd, L., “The Hair Stylist, the Corn Merchant, and the Doctor: Ambiguously Altruistic,” Journal of Law, Medicine & Ethics 42, no. 4 (2014): 509–517.CrossRefGoogle Scholar
Chiarello, E., “Medical Versus Fiscal Gatekeeping: Navigating Professional Contingencies at the Pharmacy Counter,” Journal of Law, Medicine & Ethics 42, no. 4 (2014): 518–534.CrossRefGoogle Scholar
Sage, W. M. McIlhattan, K., “Upstream Health Law,” Journal of Law, Medicine & Ethics 42, no. 4 (2014): 535–549.CrossRefGoogle Scholar